HLA-DRB1 and HLA-DQA1 associated with immunogenicity to adalimumab therapy in patients with rheumatoid arthritis. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/ard-2023-223955
PubMed Identifier: 37699653
Publication URI: http://europepmc.org/abstract/MED/37699653
Type: Journal Article/Review
Parent Publication: Annals of the rheumatic diseases
ISSN: 0003-4967